- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 22nd, 2006
BioLok International Inc. (OTC Bulletin Board: BLLI), the manufacturer and worldwide distributor of leading-edge dental implant technology, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market BoneGen-TR. The FDA clearance, which could have taken up to 90 days or longer, was granted 5 weeks after BioLok made its submission.
BoneGen-TR from BioLok, a pioneer in merging technological innovation and cell biology, is a clinically safe, nano-composite, time release calcium sulfate product used for bone regeneration, augmentation, and as a soft tissue barrier in Implantology, Periodontology, Endodontics and Oral Surgery.
|Related News Press|
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins July 26th, 2016
Accurate design of large icosahedral protein nanocages pushes bioengineering boundaries: Scientists used computational methods to build ten large, two-component, co-assembling icosahedral protein complexes the size of small virus coats July 25th, 2016
Attosecond physics: Mapping electromagnetic waveforms July 25th, 2016
Thomas Swan and NGI announce unique partnership July 28th, 2016